In memory and mourning of our Chief Scientific Officer Prof. Dr. rer. nat. Dr. med. habil. Manfred Schmitt



Prof. Dr. med. Dr. med. habil. Olaf G Wilhelm

Chief Executive Officer and Chairman of the Executive Management Board

Olaf WilhelmProf. Dr. med. Olaf G. Wilhelm is founder and Chief Executive Officer of Therawis Pharma GmbH, Munich. He also was co-founder of Wilex Biotechnology GmbH and its Managing Director from October 1, 1997 until April 8, 2001, and has been Chief Executive Officer of WILEX AG since April 9, 2001 since the conversion of the company into a stock market corporation (Wilex AG). Prof. Wilhelm managed two company acquisitions, several international development and commercialization partnerships and listed Wilex AG on the public stock Exchange. In the year 2001, he was appointed Extraordinary Professor of Gynecology at the Technical University of Munich. From 1990 to 1997, he was employed as senior physician for Obstetrics and Gynecological Oncology at the Dept. Obstetrics & Gynecology (Frauenklinik) at the Medical School of the university hospital Klinikum rechts der Isar des Klinikums rechts der Isar) at the Technical University of Munich. While at the Technical University of Munich, Prof. Wilhelm was also a member of the Clinical Research Unit of the Frauenklinik. From 1987 to 1990, he worked as a scientist for Eli Lilly and Company, Indianapolis, Indiana/USA. Prof. Wilhelm received the Midwest Trainee Award of the American Federation for Clinical Research and has authored over 70 publications. He received his MD from the Technical University of Munich. Prof. Wilhelm is a member of the senate of the “Bundeswirtschaftssenat des Bundesverbandes mittelständische Wirtschaft Deutschland e.V.” In 2011, the Technical University of Munich awarded him the title “TUM Entrepreneur of Excellence”.


Dr. rer. nat. Gabriele Schricker

Director Project Management

GS_corr1Dr. Gabriele Schricker, Director Project Management at Therawis Diagnostics GmbH, has a broad background of more than seventeen years of professional experience in international project management and information & documentation management in the field of drug development. Dr. Schricker started her professional career at a clinical CRO for 3 years and worked during the last 14 years for 6 biopharmaceutical companies in Germany, Switzerland, and Italy. She was mainly responsible for partnered co-development alliances and projects with focus in oncology (small molecules and biologics) and inflammatory diseases (biologics) leading multi-disciplinary and multi-cultural drug development teams in early to late stage development programs. In addition, she was responsible for financial and program reporting to internal and external governance committees, supervisory boards, and key stakeholders. Furthermore, Dr. Schricker has a strong expertise in implementation and optimization of project management processes, team performance, and communication. Dr. Schricker holds a PhD in Biology from the University of Cologne, Germany. After her PhD thesis in Zoology, she gained a second qualification in Scientific Information Management and earned additional qualifications in coaching and psychological counselling. Dr. Schricker is keynote speaker for project management at the European Centre for Regulatory Affairs (EUCRAF, Freiburg) since 2011.


Prof. Dr. rer. nat. Michaela Aubele

Director Research & Science

Michaela joined Therawis Diagnostics GmbH in 2017 and became Director Research & Science as of January 2018. From 1986 to 2016 she worked as a scientist at the Helmholtz Zentrum München in the field of cancer research with focus on prognostic markers in breast cancer. In 2011 Michaela was appointed Professsor in Experimental Pathology of the Medical Faculty at the Technische Universität München. In 2007 she became Deputy Chairman, and from April 2015 until October 2016 she was Acting Director of the Institute of Pathology at the Helmholtz Zentrum München. She authored more than 90 publications in international scientific journals and books and attracted third-party funds e.g. Wilhelm Sander Foundation, DFG, Bayerische Forschungsstiftung, Vaillant Stiftung and EU-funded projects e.g. ‘STORE’; ‘TRANS-BIG’; ‘PRESS’). She was reviewer for international scientific journals such as International Journal of Cancer, British Journal of Cancer, European Journal of Cancer, Journal of Pathology, Cancer Cell Biology, Oncology, Diagnostic Molecular Pathology, Pathology Research and Practice, Journal of Translational Medicine, Experimental Cell Research, Breast Cancer Research and Treatment. Michaela Aubele studied biology and earned her PhD in biology from the Institute of Anthropology and Human Genetics at the Ludwig-Maximilians-Universität, Munich.


Dr. rer. nat. Rudolf Napieralski

Manager Research & Development

Rudi_corr1Dr. Rudolf Napieralski, Manager Research & Development, is also co-founder of Therawis Diagnostics GmbH and is a chemist by training. Rudolf worked previously more than ten years in translational cancer research and several years in commercial biomarker development and genomics services. He gained significant expertise in molecular biology, translational tumor biomarker development, especially for quantitative PCR assays, cancer epigenetics and signal transduction pathways. Rudolf completed an advanced training program “Life Science management” at the ATV GmbH, Munich, gaining insight into business development processes, project management, QC and QA, health care regulations and marketing. His research at the department of obstetrics and gynecology and the Institute of Pathology, Technical University of Munich, focused on conducting and managing clinical tumor biomarker development in national and international clinical trials. Rudolf’s industrial career included positions as Manager R&D for the development of single cell qRT-PCR assays at the GILUPI GmbH and Project Assistant at Eurofins Genomics GmbH (formerly Eurofins Medigenomics GmbH). Dr. Napieralski earned his PhD in Biochemistry in the field of adenosine mediated signal transduction pathways from the Institute of Anthropology and Human Genetics at the Ludwig Maximilians University, Munich.